Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy

Area of Science:

• Immunotherapy
• Cellular Therapy
• Cancer Research

Background:

• Chimeric antigen receptor (CAR)-T cell therapy is effective for hematologic malignancies but has limitations for solid tumors, including adverse effects and high costs.
• CAR-NK cell therapy presents an alternative, offering an off-the-shelf, safer, and more affordable product with potential for solid tumor treatment.

Purpose of the Study:

• To review current gene manipulation tools for enhancing CAR-NK cell therapy.
• To discuss the advantages and disadvantages of these gene manipulation strategies.
• To explore how these tools can improve the safety and efficacy of CAR-NK cell therapy.

Main Methods:

• Review of existing literature on CAR-NK cell therapy and gene manipulation techniques.
• Analysis of preclinical and clinical study results.
• Discussion of gene editing tools and their applications in CAR-NK cell development.

Main Results:

• CAR-NK cell therapy shows promise but faces challenges like low *in vivo* persistence, tumor trafficking, and efficacy in solid tumors.
• Gene manipulation tools are advancing, offering strategies to overcome these limitations.
• These tools can potentially enhance the safety and effectiveness of CAR-NK cell therapy.

Conclusions:

• Gene manipulation is crucial for unlocking the full potential of CAR-NK cell therapy.
• Advances in gene editing are paving the way for improved CAR-NK cell products.
• Further research and development are needed to optimize CAR-NK cell therapy for broader clinical application.